Cargando…
Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages
The Bowman-Birk inhibitor (BBI), a soybean-derived protease inhibitor, is known to have anti-inflammatory effect in both in vitro and in vivo systems. Macrophages play a key role in inflammation and immune activation, which is implicated in HIV disease progression. Here, we investigated the effect o...
Autores principales: | Ma, Tong-Cui, Zhou, Run-Hong, Wang, Xu, Li, Jie-Liang, Sang, Ming, Zhou, Li, Zhuang, Ke, Hou, Wei, Guo, De-Yin, Ho, Wen-Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062087/ https://www.ncbi.nlm.nih.gov/pubmed/27734899 http://dx.doi.org/10.1038/srep34752 |
Ejemplares similares
-
Corrigendum: Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages
por: Ma, Tong-Cui, et al.
Publicado: (2016) -
Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages
por: Li, Jieliang, et al.
Publicado: (2011) -
Identification and Target-Modification of SL-BBI: A Novel Bowman–Birk Type Trypsin Inhibitor from Sylvirana latouchii
por: Chen, Xi, et al.
Publicado: (2020) -
Effects of Alpha-Connexin Carboxyl-Terminal Peptide (aCT1) and Bowman-Birk Protease Inhibitor (BBI) on Canine Oral Mucosal Melanoma (OMM) Cells
por: Sato, Ayami, et al.
Publicado: (2021) -
Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide–PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer
por: Lyu, Peng, et al.
Publicado: (2018)